Towa Pharmaceutical Co 4553.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4553.T. It has been listed since 5 April 2004. In the fiscal year to 31 March 2026, it reported revenue of ¥273.71bn and net income of ¥5.25bn. At that date it held total assets of ¥475.29bn and shareholders' equity of ¥178.10bn.

Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Kadoma-Shi, Osaka-Fu. The company went IPO on 2004-04-05. Its main products are generic drugs, which include nervous system drugs, allergy drugs, cardiovascular drugs, hormone drugs, vitamin drugs, metabolic drugs, antibiotic drugs and chemotherapy drugs, among others.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Itsuro YoshidaPresident, Chairman of Subsidiary, Representative Director, since 1996
• Mr. Shiro HatagamiExecutive Officer, Chief Director of Accounting and Finance
• Mr. Osamu UchikawaChairman of Subsidiary, Director, since 2019
• Mr. Shigehiro KuboSenior Executive Officer, Chief Director of International Business, Director of Asia Regional Business
• Mr. Yutaka OkudaSenior Executive Officer, Chief Director of R&D, Senior Director of Fundamental Technology, Director of Innovation Research, since 2024
• Mr. Tetsuro TabataSenior Executive Officer, Chief Director of Production
• Mr. Masaji MorikawaExecutive Officer, Deputy Chief Director of Main Sales Unit, Director of Hospital Promotion
• Mr. Yasuyuki OishiExecutive Officer, Chief Director of Sales, Manager of Promote Stable Supply
• Mr. Shigeki FujitaExecutive Officer, Manager of Human Resource Research Center, since 2024
• Mr. Keisuke HiraiExecutive Officer, Senior Director of Product Planning in Main R & D Unit
• Mr. Norikazu InoueExecutive Officer, Chief Director of Administration, since 2017
• Mr. Takayuki KannoExecutive Officer, Manager of Yamagata Plant in Main Production Plant, Director of Engineering, since 2024

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.